969
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell response

, , , , , , , , , & ORCID Icon show all
Pages 653-670 | Received 25 Oct 2023, Accepted 07 Mar 2024, Published online: 26 Mar 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.